These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 3880559

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
    Krarup T, Madsbad S, Moody AJ, Regeur L, Faber OK, Holst JJ, Sestoft L.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
    [Abstract] [Full Text] [Related]

  • 3. Relation of immunoreactive gastric inhibitory polypeptide to changes in glycaemic control and B cell function in type 1 (insulin-dependent) diabetes mellitus.
    Krarup T, Madsbad S, Regeur L, Faber OK, Tronier B.
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):221-5. PubMed ID: 6364671
    [Abstract] [Full Text] [Related]

  • 4. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T, Krarup T, Sonne J, Madsbad S, Vølund A, Juul AG, Holst JJ.
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [Abstract] [Full Text] [Related]

  • 5. Gastric inhibitory polypeptide in newly diagnosed ketotic type I (insulin-dependent) diabetics.
    Krarup T, Madsbad S, Moody AJ.
    Acta Med Scand; 1988 Jun; 223(5):437-41. PubMed ID: 3287838
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of exogenous insulin on fasting serum levels of gastric inhibitory polypeptide (GIP) in juvenile diabetes.
    Talaulicar M, Ebert R, Willms B, Creutzfeldt W.
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):175-80. PubMed ID: 7021006
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of gastric inhibitory polypeptide (GIP) release by insulin and glucose in juvenile diabetes.
    Creutzfeldt W, Talaulicar M, Ebert R, Willms B.
    Diabetes; 1980 Feb; 29(2):140-5. PubMed ID: 6986299
    [Abstract] [Full Text] [Related]

  • 17. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
    Arnold R, Creutzfeldt W, Ebert R, Becker HD, Börger HW, Schafmayer A.
    Scand J Gastroenterol; 1978 Feb; 13(1):41-7. PubMed ID: 635445
    [Abstract] [Full Text] [Related]

  • 18. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
    Ebert R, Frerichs H, Creutzfeldt W.
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.